OOIR: Observatory of International Research

Papers

(The TQCC of International Journal of Laboratory Hematology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Laboratory testing for suspected COVID‐19 vaccine–induced (immune) thrombotic thrombocytopenia	67
COVID‐19 and hematology findings based on the current evidences: A puzzle with many missing pieces	55
The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID‐19	48
ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID‐19: Evidence of SARS‐CoV‐2 induced secondary thrombotic microangiopathy	43
COVID‐19: Thrombosis, thromboinflammation, and anticoagulation considerations	38
Machine learning in health care and laboratory medicine: General overview of supervised learning and Auto‐ML	37
International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing	33
COVID‐19–related laboratory coagulation findings	31
Age‐ and sex‐specific pediatric reference intervals for neutrophil‐to‐lymphocyte ratio, lymphocyte‐to‐monocyte ratio, and platelet‐to‐lymphocyte ratio	28
Plasmablastic lymphoma: An update	27
SARS‐CoV‐2 infection induces soluble platelet activation markers and PAI‐1 in the early moderate stage of COVID‐19	27
Diagnosis and treatment of thrombotic microangiopathy	26
Heparin dosage, level, and resistance in SARS‐CoV2 infected patients in intensive care unit	25
A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS‐CoV‐2 vaccine	24
Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid‐19 patients	23
How I investigate acquired megaloblastic anemia	23
The hemoglobinopathies, molecular disease mechanisms and diagnostics	22
International Council for Standardisation in Haematology (ICSH) recommendations for collection of blood samples for coagulation testing	22
Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID‐19 infection	22
Validation of monocyte distribution width decisional cutoff for sepsis detection in the acute setting	21
2021 update of the 2012 ICSH Recommendations for identification, diagnostic value, and quantitation of schistocytes: Impact and revisions	21
Evaluation of Scopio Labs X100 Full Field PBS: The first high‐resolution full field viewing of peripheral blood specimens combined with artificial intelligence‐based morphological analysis	21
Platelets: "multiple choice" effectors in the immune response and their implication in COVID‐19 thromboinflammatory process	21
Higher coagulation activity in hip fracture patients: A case‐control study using rotational thromboelastometry	20
The complicated relationships of heparin‐induced thrombocytopenia and platelet factor 4 antibodies with COVID‐19	19

Platelet factor 4 triggers thrombo‐inflammation by bridging innate and adaptive immunity	18
Gene therapy for hemophilia: Current status and laboratory consequences	17
Pooled analysis of monocyte distribution width in subjects with SARS‐CoV‐2 infection	16
Comparison of RNA‐ and DNA‐based methods for measurable residual disease analysis in NPM1‐mutated acute myeloid leukemia	16
Measuring residual anti‐Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa	16
International Council for Standardization in Haematology (ICSH) laboratory guidance for the verification of haemostasis analyser‐reagent test systems. Part 2: Specialist tests and calibrated assays	15
The hematology laboratory’s response to the COVID‐19 pandemic: A scoping review	15
Adhesion molecule immunophenotype of bone marrow multiple myeloma plasma cells impacts the presence of malignant circulating plasma cells in peripheral blood	14
Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma	14
Unsupervised flow cytometry analysis in hematological malignancies: A new paradigm	14
Multicentric evaluation of the new HemosIL Acustar^® chemiluminescence ADAMTS13 activity assay	13
Changes in peripheral blood cellular morphology as diagnostic markers for COVID‐19 infection	13
Circ_0009910 sponges miR‐491‐5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K/AKT signaling pathway	13
Diagnostic and prognostic utility of WBC counts and cell population data in patients with COVID‐19	13
Significance of RDW in predicting mortality in COVID‐19—An analysis of 622 cases	12
Interpreting sulfhemoglobin and methemoglobin in patients with cyanosis: An overview of patients with M‐hemoglobin variants	12
Trimester‐specific thromboelastic values and coagulation activation markers in pregnancy compared across trimesters and compared to the nonpregnant state	12
Using a low–molecular weight heparin–calibrated anti–factor Xa assay to assess the concentration of apixaban and rivaroxaban	12
Effects of circadian variation, lifestyle and environment on hematological parameters: A narrative review	12
Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab	12
Update on platelet procoagulant mechanisms in health and in bleeding disorders	12
To B‐ or not to B‐: A review of lineage switched acute leukemia	12
Laboratory approach to investigation of anemia in pregnancy	11
Increasing ferritin predicts early death in adult hemophagocytic lymphohistiocytosis	11
Monocyte distribution width adds prognostic value in detection of COVID‐19 respiratory failure	11
A multi‐laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network	11
Plasma levels do not predict thrombin generation in patients taking direct oral anticoagulants	11
Diagnostic value of white blood cell parameters for COVID‐19: Is there a role for HFLC and IG?	10
Upregulation of ATIC in multiple myeloma tissues based on tissue microarray and gene microarrays	10
How to best monitor bivalirudin anticoagulant effect for ECMO and VAD—Comparison of four assay methods	10
Evaluation of measurable residual disease in multiple myeloma by multiparametric flow cytometry: Current paradigm, guidelines, and future applications	10
Neutrophil‐to‐lymphocyte and platelet‐to‐lymphocyte ratios as prognostic biomarkers in polycythemia vera	10
Diagnosing heparin‐induced thrombocytopenia: The need for accuracy and speed	10
International Council for Standardization in Haematology (ICSH) laboratory guidance for the evaluation of haemostasis analyser‐reagent test systems. Part 1: Instrument‐specific issues and commonly use	10
Performance evaluation of the new hematology analyzer UniCel DxH 900	10
Hemophagocytic histiocytosis in severe SARS‐CoV‐2 infection: A bone marrow study	10
ADAMTS13 testing update: Focus on laboratory aspects of difficult thrombotic thrombocytopenic purpura diagnoses and effects of new therapies	9
Application of an optimized interpretation model in capillary hemoglobin electrophoresis for newborn thalassemia screening	9
CXCL2 benefits acute myeloid leukemia cells in hypoxia	9
Detection and significance of green inclusions in peripheral blood neutrophils and monocytes	9
CaMKIIγ regulates the viability and self‐renewal of acute myeloid leukaemia stem‐like cells by the Alox5/NF‐κB pathway	9
Increased monocyte distribution width in COVID‐19 and sepsis arises from a complex interplay of altered monocyte cellular size and subset frequency	9
Stability and comparison of complete blood count parameters between capillary and venous blood samples	9
Expression and prognostic relevance of long noncoding RNAs CRNDE and AOX2P in adult acute myeloid leukemia	9
The characteristic peripheral blood morphological features of hospitalized patients infected with COVID‐19	9
The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma	9
Laboratory methods for monitoring argatroban in heparin‐induced thrombocytopenia	9
Plasma hemoglobin: A method comparison of six assays for hemoglobin and hemolysis index measurement	9
Features of serum complement C3 and C4 levels in autoimmune hemolytic anemia patients	8
Full spectrum flow cytometry in the clinical laboratory	8

Downregulation of Lymphoid enhancer‐binding factor 1 (LEF‐1) expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologi	8
Harmonizing platelet function analyzer testing and reporting in a large laboratory network	8
New insights into genetic characteristics between multiple myeloma and COVID‐19: An integrative bioinformatics analysis of gene expression omnibus microarray and the cancer genome atlas data	8
Peripheral granular lymphocytopenia and dysmorphic leukocytosis as simple prognostic markers in COVID‐19	8
Development and exacerbation of autoimmune hemolytic anemia following COVID‐19 vaccination: A systematic review	8
Pneumatic tube transport of blood samples affects global hemostasis and platelet function assays	8
Estimating plasma volume using the Strauss‐derived formula may improve prognostication in polycythemia vera	8
Implementation of the new EUR IVD regulation and relation with ISO15189 accreditation: Guidance is urgently required for haemostasis testing	8
Major rise of a chronic lymphoid leukemia clone during the course of COVID‐19	8
Study of in vitro thrombin generation after neutralization of heparin	8
Circulating tumor DNA by high‐throughput sequencing of T cell receptor monitored treatment response and predicted treatment failure in T cell lymphomas	8
Evaluation of the accuracy of immature granulocyte percentage in predicting pediatric serious bacterial infection	8
The effect of DOAC‐Stop^® on several oral and parenteral anticoagulants	8
Identification of thalassemia gene cluster deletion by long‐read whole‐genome sequencing (LR‐WGS)	8
Low clinical utility of testing for anti‐platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV‐19 vaccine	8
Differences between capillary and venous blood counts in children—A data mining approach	8
Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months	7
Standardization and harmonization in hematology: Instrument alignment, quality control materials, and commutability issue	7
Aiding clinical assessment of neonatal sepsis using hematological analyzer data with machine learning techniques	7
Early detection of Candida parapsilosis sepsis in peripheral blood as a result of cytografic changes on the Sysmex XN‐3000 hematology analyzer	7
Continuous reference curves for common hematology markers in the CALIPER cohort of healthy children and adolescents on the Sysmex XN‐3000 system	7
Association of FOXP3 gene polymorphisms with chronic immune thrombocytopenia in a Chinese Han population	7
Comparison of flow cytometry and next‐generation sequencing in minimal residual disease monitoring of acute myeloid leukemia: One institute’s practical clinical experience	7
Predicting bacteraemia in maternity patients using full blood count parameters: A supervised machine learning algorithm approach	7
Digital morphology in hematology diagnosis and education: The experience of the European LeukemiaNet WP10	7
Erythropoiesis changes with increasing age in the elderly Chinese	7
International Council for Standardization in Haematology recommendations for laboratory measurement of factorVIIIandFIXtypeIinhibitors	7
Screening of myelodysplastic syndrome using cell population data obtained from an automatic hematology analyzer	7
The lncRNA SLCO4A1‐AS1/miR‐876‐3p/RBBP6 axis regulates cell proliferation and apoptosis in acute lymphocytic leukemia via the JNK signaling pathway	7
Cell Population Data NE‐WX, NE‐FSC, LY‐Y of Sysmex XN‐9000 can provide additional information to differentiate macrocytic anaemia from myelodysplastic syndrome: A preliminary study	7
Transient increase in blast count following COVID‐19 infection mimicking acute leukemia	7
Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor‐discontinuation” in chronic myeloid leukemia	7
Neutrophil‐to‐lymphocyte ratio is independently associated with COVID‐19 severity: An updated meta‐analysis based on adjusted effect estimates	7
How I investigate dysgranulopoiesis	7
Review of coagulation preanalytical variables with update on the effect of direct oral anticoagulants	7
How I investigate minimal residual disease in acute lymphoblastic leukemia	7
Reduced expansion of CD94/NKG2C⁺ NK cells in chronic lymphocytic leukemia and CLL‐like monoclonal B‐cell lymphocytosis is not related to increased human cytomegalovirus seronegativity or	6
Applied machine learning in hematopathology	6
Quantification and optimization of clot retraction in washed human platelets by Sonoclot coagulation analysis	6
Unusual inclusions in cerebrospinal fluid macrophages of spinal muscular atrophy patients treated with nusinersen	6
Reference intervals of white blood cell parameters for healthy adults in japan	6
CD34 negative HLA‐DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3‐ITD mutations	6
In support of interoperability: A laboratory perspective	6
Spectrum mutations of PRF1, UNC13D, STX11, and STXBP2 genes in Vietnamese patients with hemophagocytic lymphohistiocytosis	6
Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia	6
Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing	6
Effect of the sequence of pull of bone marrow aspirates on plasma cell quantification in plasma cell proliferative disorders	6
A stepwise haematological screening and whole‐exome sequencing reveal multiple mutations from SUPT5H causing an elevation of Hb A₂ from a cohort of 47336 indivi	6
Schistocyte quantitation, thrombotic microangiopathy and acute kidney injury in Australian snakebite coagulopathy [ASP28]	6
Characteristic vacuolization of myeloid precursors and UBA1 mutation in a woman with monosomy X	6
Serious consequences of Epstein‐Barr virus infection: Hemophagocytic lymphohistocytosis	6
Do congenital bleeding disorders have a protective effect against COVID‐19? A prospective study	6
Thrombin generation abnormalities in commonly encountered platelet function disorders	6
Rapid screening of dengue fever using research parameters from new generation hematological analyzers	6
Performance evaluation of the new platelet measurement channel on the BC‐6800 Plus automated hematology analyzer	6
Enumeration and phenotyping of circulating microvesicles by flow cytometry and nanoparticle tracking analysis: Plasma versus serum	6
The diagnostic accuracy of Sysmex XN for identification of pseudothrombocytopenia using various thresholds for definition of platelet aggregation	6
Profile of antiphospholipid antibodies in HIV‐infected and HIV‐uninfected women with a history of thrombosis	6
Technological features of blast identification in the cerebrospinal fluid: A systematic review of flow cytometry and laboratory haematology methods	6
White blood cell evaluation in haematological malignancies using a web‐based digital microscopy platform	6
Red cell distribution width and in‐hospital mortality in septic shock: A public database research	6
Complete blood count and cell population data parameters from the Abbott Alinity hq analyzer are useful in differentiating myelodysplastic syndromes from other forms of cytopenia	6
The relative expression levels of CD148 and CD180 on clonal B cells and CD148/CD180 median fluorescence intensity ratios are useful in the characterization of mature B cell lymphoid neoplasms infiltra	6
Functional multigenic variations associated with hodgkin lymphoma	6
Pathophysiology and management of bleeding and thrombosis in patients with liver disease	6
Laboratory evaluation and prognostication among adults and children with CEBPA‐mutant acute myeloid leukemia	6
Parameters of the complete blood count predict in hospital mortality	6
Cytomorphology of normal, reactive, dysmorphic, and dysplastic megakaryocytes in bone marrow aspirates	6
High immature platelet fraction with reduced platelet count on hospital admission. Can it be useful for COVID‐19 diagnosis?	6
Morphology of myeloproliferative neoplasms	5
Reference intervals of automated reticulocyte count and immature reticulocyte fraction in a pediatric population	5
Differential diagnosis of thalassemia and iron deficiency anemia using the CellaVision Advanced Red Blood Cell software	5
Interference of D‐dimer levels from heterophilic antibody in COVID‐19: A serious concern in treatment and follow‐up of patients	5
CD26 expression on circulating CD34+/CD38‐ progenitor population is a specific and reliable tool for the rapid flow cytometric diagnosis of chronic myeloid leukemia—A single‐center validation study	5
Evaluation of Sigma metric approach for monitoring the performance of automated analyzers in hematology unit of Alexandria Main University Hospital	5
Limitations of a calibrated, quantitative APC‐R assay under routine conditions	5
Neonatal haemostatic parameters in correlation to gestational age and birth weight	5
Measurement of hematopoietic progenitor cells using XN2000 hematology analyzer	5
Epigenetic analysis reveals significant differential expression of miR‐378C and miR‐128‐2‐5p in a cohort of relapsed pediatric B‐acute lymphoblastic leukemia cases	5
Persistent hiccups in a patient with mild congenital factor V deficiency and COVID‐19; clinical and laboratory finding of a rare bleeding disorder	5

Standardization of reticulocyte counts in the athlete biological passport: A practical update	5
Machine learning models outperform manual result review for the identification of wrong blood in tube errors in complete blood count results	5
Concordance between flow cytometry CLL scores	5
Viscoelastic testing: Critical appraisal of new methodologies and current literature	5
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials	5
Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia	5
Prospective evaluation of two specific IgG immunoassays (HemosIL^® AcuStar HIT‐IgG and HAT45G^®) for the diagnosis of heparin‐induced thrombocytopenia: A Bayesian approach	5
Expression of CD304/neuropilin‐1 in adult b‐cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment	5
Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia	5
Independent prognostic significance of TP53 mutations in adult acute myeloid leukaemia with complex karyotype	5
Performance evaluation of platelet counting of Abbott Alinity hq and Sysmex XN‐9000 automated hematology analyzer compared with international reference method	5
Performance evaluation of coaguchek pro II in comparison with coaguchek XS plus and sta‐r Max using a sta‐neoplastine CI plus	5
The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm	5
Assessing maternal clotting function with novel global coagulation assays: A prospective pilot study	5
Biological variation data and analytical specification goal estimates of the thrombin generation assay with and without thrombomodulin in healthy individuals	5
Additional mutations in IDH1/2‐mutated patients with acute myeloid leukemia	5
A simplified diagnostic pathway for the differential diagnosis of iron deficiency anaemia and anaemia of chronic disease	5
Evaluation and comparison of the new Mindray BC‐6200 hematology analyzer with ADVIA 2120i	5
GATA1 mutation analysis and molecular landscape characterization in acute myeloid leukemia with trisomy 21 in pediatric patients	5
Mutational landscape of Juvenile Myelomonocytic Leukemia (JMML)—A real‐world context	5
Experimental evaluation of deep learning method in reticulocyte enumeration in peripheral blood	5
Automated differential diagnosis method for iron deficiency anemia and beta thalassemia trait based on iterative Chi2 feature selector	5
TTMV::RARA‐driven myeloid sarcoma in pediatrics with germline SAMD9 mutation and relapsed with refractory acute promyelocytic leukemia	5
Analysis of laboratory blood parameter results for patients diagnosed with COVID‐19, from all ethnic group populations: A single centre study	5
Immature platelet fraction over time and clinical outcomes in patients with acute myocardial infarction	5
Utility of CD229 as novel marker in measurable residual disease assessment in multiple myeloma—An evidence‐based approach	4
A single‐institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting	4
Revisiting the effects of spectral interfering substances in optical end‐point coagulation assays	4
Lymphocytes screening on admission is essential for predicting in‐hospital clinical outcome in COVID‐19 patients: A retrospective cohort study	4
Digital assessment of peripheral blood and bone marrow aspirate smears	4
Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levels	4
The combination of emicizumab and recombinant factor VIII in plasma: Which assays can we use for accurate measurement?	4
Stability of coagulation parameters in plasma samples at room temperature after one freeze/thaw cycle	4
ICSH guidance for INR and D‐dimer testing using point of care testing in primary care	4
A retrospective study of age‐defined hematologic inflammatory markers related to pediatric COVID‐19 diagnosis	4
Blister and bite cells in G6PD deficiency	4
Characterization and identification of Prachinburi β⁰‐thalassemia: A novel‐60 kb deletion in beta globin gene related to high levels of Hb F in heterozygous state	4
Establishment of pediatric reference intervals for complete blood count parameters in capillary blood in Beijing	4
Comparison of the performance of two automatic cell morphology analyzers for peripheral‐blood leukocyte morphology analysis: Mindray MC‐100i and Sysmex DI‐60	4
Validation of a rapid potency assay for cord blood stem cells using phospho flow cytometry: The IL‐3‐pSTAT5 assay	4
The modification of the thrombin generation assay for the clinical assessment of hypercoagulability in patients receiving heparin therapy	4
Blue‐green cytoplasmic inclusions in neutrophils/monocytes of patients with yellow fever	4
U2AF1 expression is a novel and independent prognostic indicator of childhood T‐lineage acute lymphoblastic leukemia	4
Measurement of antifactor VIII antibody titre in the presence of emicizumab; Use of chromogenic Bethesda assays	4
Soluble Transferrin Receptor during infancy and reference intervals for the Roche Cobas platform	4
The role of cystatin C in multiple myeloma	4
A Systematic review on diagnostic methods of red cell membrane disorders in Asia	4
Clinicopathological and immunophenotypic features of early T cell precursor acute lymphoblastic leukaemia: A flow cytometry score for the initial diagnosis	4
Chimeric antigen receptor T‐cells: Properties, production, and quality control	4
Multicentric evaluation of the variability of digital morphology performances also respect to the reference methods by optical microscopy	4
Identification of novel mutations in patients with Diamond‐Blackfan anemia and literature review of RPS10 and RPS26 mutations	4
International council for standardisation in haematology recommendations on fibrinogen assays, thrombin clotting time and related tests in the investigation of bleeding disorders	4
Artificial intelligence and the blood film: Performance of the MC‐80 digital morphology analyzer in samples with neoplastic and reactive cell types	4
Vivax malaria detection using a parasitic red blood cell flag generated by the Sysmex XN‐9000 hematology analyzer	4
Correlation of hematological parameters and cycle threshold in ambulatory patients with SARS‐CoV‐2 infection	4
An evaluation of the Japanese Society on Thrombosis and Hemostasis criteria for disseminated intravascular coagulation as a predictor of prognosis in patients with infection	4
Defining ferritin clinical decision limits to improve diagnosis and treatment of iron deficiency: A modified Delphi study	4
Improving the efficiency of the autoverification workflow for nucleated red blood cell reporting in the hematology laboratory	4
Accuracy study of a novel alternate method measuring erythrocyte sedimentation rate for prototype hematology analyzer Celltac α+	4
Correlation between leukocyte‐platelet aggregates and thrombosis in myeloproliferative neoplasms	4
Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania	4
Evaluation of pretreatment telomere length as a prognostic marker in intermediate‐risk acute myeloid leukemia	4
Clinical and molecular characteristics of imerslund‐gräsbeck syndrome: First report of a novel Frameshift variant in Exon 11 of AMN gene	4
The value of next‐generation sequencing in routine diagnostics and management of patients with cytopenia	4
Expression of BCL11A in chronic lymphocytic leukaemia	4
How I investigate difficult cells at the optical microscope	4
ICSH guidance for internal quality control policy for blood cell counters	4
Karyotypic complexity, TP53 pathogenic variants, and increased number of variants on Next‐Generation Sequencing are associated with disease progression in a North American Adult T‐Cell Leukemia/Lympho	4
Higher accuracy of surgical over core needle biopsy for the diagnosis of lymphoproliferative disorders	4
Mixing factor Xa and thrombin inhibiting direct oral anticoagulants produces a synergistic prolonging effect on most clotting tests	3
Effect of direct thrombin inhibitors on laboratory measurement of fibrinogen: Potential for errors in clinical decision‐making	3
Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPAL^isoMPO is distinct from other MPAL subtypes	3
Alectinib‐induced red cell morphological changes in a patient with underlying α‐thalassaemia trait	3
Analytical validation of white blood cell differential and platelet assessment on the Sysmex DI‐60 digital morphology analyzer	3
Early hematological indicators of severe COVID‐19 disease in hospitalized patients: Data from a South Asian population	3
The effect of erythrocyte lysing reagents on enumeration of leukocyte subpopulations compared with a no‐lyse‐no‐wash protocol	3
Measurement of immature platelet fraction is useful in the differential diagnosis of MYH9 disorders	3
Identifying a malignant B‐cell lymphoma clone in peripheral blood using immunoglobulin high‐throughput sequencing and lineage tree analysis	3
Value of new advanced hematological parameters in early prediction of severity of COVID‐19	3
Neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio as new possible minor criteria for diagnosis of polycythemia vera	3
Change in platelet indices in patients with Coronavirus disease‐2019 (COVID‐19): A reflection of platelet activation and contribution to immunothrombosis?	3
Blast size‐specific flowcytometric ploidy assessment using FxCycle^TM Violet dye and its correlation with conventional cytogenetic ploidy in pediatric precursor B‐lineage acute lymphoblastic	3
Clinical utility of Abbott Alinity hq extended red blood cell parameters in differentiating β‐thalassemia trait and iron deficiency anemia	3
Comparison of platelet count results on the Sysmex XN between citrate or MgSO₄ and K2 EDTA anticoagulants	3
Assessment of acquired activated protein C resistance with the FibWave and comparison with the ETP‐based APC resistance	3
Green neutrophilic inclusions in meningococcal sepsis	3
Automated measurement of coagulation and fibrinolytic activation markers: Outcomes in coronavirus disease 2019 (COVID‐19) patients	3
Acute myeloid leukemia with RAM immunophenotype: A new underdiagnosed entity	3
Breakpoint characterization of a rare alpha⁰‐thalassemia deletion using targeted locus amplification on genomic DNA	3
White blood cell differentials performance of a new automated digital cell morphology analyzer: Mindray MC‐80	3
Significance of WT1 and multiparameter flow cytometry assessment in patients with chronic myelomonocytic leukemia receiving allogeneic hematopoietic stem cell transplantation	3
A case of azathioprine‐induced aplastic anemia	3
Is monitoring of antiplatelet therapy by light transmission aggregometry dependent on instrument and reagent used?	3
The evaluation of overall hemostatic potential assay in patients with COVID‐19 infection	3
Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?	3